AGP Executive Report
Last update: a day agoPublic Health & Travel: A Dutch-flagged cruise ship tied to a hantavirus outbreak in the Canaries has been cleared to resume sailing after cleaning and disinfection in Rotterdam, with the WHO noting 13 confirmed cases linked to the incident and no vaccine or specific treatment for hantavirus. Cancer Care: New Phase 3 data from SENOMAC suggest omitting axillary lymph node dissection can be non-inferior for survival while cutting arm complications in selected breast cancer patients. Oncology Trials: Orion Pharma reported early Phase 1/2 results for TEAD inhibitor ODM-212 in advanced solid tumours, while BioNTech and BMS shared interim ROSETTA Lung-02 findings for pumitamig plus chemotherapy in first-line NSCLC. Patient Quality of Life: Secondary COMPETE analysis reports better health-related quality of life with 177Lu-edotreotide versus everolimus in GEP-NETs. Wellness & Aging: A study links a more anti-inflammatory dietary pattern with lower colorectal cancer risk, and separate research points to a sleep “sweet spot” associated with healthier aging. Ebola Response: WHO chief Tedros visited Bunia in eastern Congo, urging community trust and safe burials as cases rise in a rare Ebola outbreak.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
.jpg)
